Lessons from controversy: biomarkers evaluation
Author:
- 29 August 2012
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 51 (2) , 247-248
Abstract
Article Lessons from controversy: biomarkers evaluation was published on February 1, 2013 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 51, issue 2).Keywords
This publication has 7 references indexed in Scilit:
- What Information Should Be Required to Support Clinical “Omics” Publications?Clinical Chemistry, 2011
- Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?Clinical Chemistry and Laboratory Medicine (CCLM), 2011
- Evaluating laboratory diagnostic tests and translational researchClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Medicare and Medical Technology — The Growing Demand for Relevant OutcomesNew England Journal of Medicine, 2010
- Challenges of the “Omics” Future and Pathology Informatics Systems: Are We—Pathologists, Clinicians, and Consumers—Ready?Archives of Pathology & Laboratory Medicine, 2009
- Evaluating New Diagnostic Technologies: Perspectives in the UK and USClinical Chemistry, 2008
- Evaluating laboratory diagnostic testsBMJ, 2008